Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Recent Signals

Date Stock Signal Type
2021-05-14 ANIC Crossed Above 50 DMA Bullish
2021-05-14 AZN NR7 Range Contraction
2021-05-14 AZN Narrow Range Bar Range Contraction
2021-05-14 AZN Stochastic Reached Overbought Strength
2021-05-14 AZN 200 DMA Support Bullish
2021-05-14 C4XD Crossed Above 50 DMA Bullish
2021-05-14 C4XD Crossed Above 20 DMA Bullish
2021-05-14 CIR 20 DMA Support Bullish
2021-05-14 FAB MACD Bearish Centerline Cross Bearish
2021-05-14 FAB Narrow Range Bar Range Contraction
2021-05-14 FAB Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 FARN NR7 Range Contraction
2021-05-14 FARN Narrow Range Bar Range Contraction
2021-05-14 GEC Stochastic Reached Oversold Weakness
2021-05-14 GEC Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 GEC 20 DMA Resistance Bearish
2021-05-14 GEC 50 DMA Resistance Bearish
2021-05-14 MTPH Narrow Range Bar Range Contraction
2021-05-14 MTPH 180 Bearish Setup Bearish Swing Setup
2021-05-14 SCLP Doji - Bullish? Reversal
2021-05-14 SPX Crossed Above 20 DMA Bullish
2021-05-14 VAL MACD Bullish Signal Line Cross Bullish
2021-05-14 VAL Expansion Pivot Buy Setup Bullish Swing Setup
2021-05-14 VAL 200 DMA Resistance Bearish
2021-05-14 VAL Crossed Above 20 DMA Bullish
2021-05-14 VAL Crossed Above 50 DMA Bullish
2021-05-14 VAL Wide Range Bar Range Expansion

Recent News for Biopharmaceutical Stocks

Date Stock Title
May 14 AZN People choosing to ditch their masks will be a ‘gradual process’: Doctor
May 14 AZN Delaying second Pfizer COVID-19 shot boosts immune response in over-80s, study finds
May 14 AZN Emergent (EBS) Issues Plan to Resume Bayview Facility Operation
May 14 AZN INSIGHT-Big promises, few doses: why Russia's struggling to make Sputnik V doses
May 13 AZN CDC approves those fully vaccinated to largely ditch masks indoors
May 13 AZN UPDATE 1-Quebec stops offering first doses of AstraZeneca vaccine
May 13 AZN UK Study Answers Question If Two Doses Of COVID-19 Vaccines Can Be Mix-Matched?
May 13 AZN Global tally of COVID-19 cases tops 160 million as U.S. gears up to vaccinate 12- to 15-year-olds
May 13 AZN What the Yankees COVID-19 outbreak proves: no vaccine is 100% effective
May 13 GEC General Electric, Raytheon Technologies, and the $7 Billion Race
May 13 AZN New Tezepelumab Data Continue to Strengthen Profile for a Broad Population of Severe Asthma Patients
May 13 AZN Mixing Pfizer and AstraZeneca Vaccines Increases Mild Side Effects but Is Safe, Study Shows
May 13 AZN Mixing Pfizer and AstraZeneca COVID-19 vaccines increases mild side effects but is safe, study shows
May 13 AZN Blood Expert Says He Found Why Some Covid-19 Vaccines Trigger Rare Clots
May 13 AZN UPDATE 1-Australia in 'active talks' with Moderna to produce COVID-19 vaccines onshore
May 12 AZN CDC panel endorses Pfizer’s Covid vaccine for use in adolescents
May 12 AZN UK Rethinks COVID-19 Antibody Supply Deal With AstraZeneca: Bloomberg
May 12 GEC GE Renewable Energy Turbines to Power First Major U.S. Offshore Wind Farm
May 12 GEC Top-Paid CEOs Make You Rich, Too
May 12 GEC The offshore wind industry just got a big boost as the U.S. approves the first wind farm off Martha’s Vineyard

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
Terminology surrounding biopharmaceuticals varies between groups and entities, with different terms referring to different subsets of therapeutics within the general biopharmaceutical category. Some regulatory agencies use the terms biological medicinal products or therapeutic biological product to refer specifically to engineered macromolecular products like protein- and nucleic acid-based drugs, distinguishing them from products like blood, blood components, or vaccines, which are usually extracted directly from a biological source. Specialty drugs, a recent classification of pharmaceuticals, are high-cost drugs that are often biologics. The European Medicines Agency uses the term advanced therapy medicinal products (ATMPs) for medicines for human use that are "based on genes, cells, or tissue engineering", including gene therapy medicines, somatic-cell therapy medicines, tissue-engineered medicines, and combinations thereof. Within EMA contexts, the term advanced therapies refers specifically to ATMPs, although that term is rather nonspecific outside those contexts.
Gene-based and cellular biologics, for example, often are at the forefront of biomedical research, and may be used to treat a variety of medical conditions for which no other treatments are available.In some jurisdictions, biologics are regulated via different pathways than other small molecule drugs and medical devices.The term biopharmacology is sometimes used to describe the branch of pharmacology that studies biopharmaceuticals.

More about Biopharmaceutical
Browse All Tags